Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Gabriella Matera, Mario Cazzola & Paola Rogliani. (2020) Evaluation of fluticasone propionate/salmeterol for the treatment of COPD: a systematic review. Expert Review of Respiratory Medicine 14:6, pages 621-635.
Read now
Read now
Henry Chrystyn & Federico Lavorini. (2020) The dry powder inhaler features of the Easyhaler that benefit the management of patients. Expert Review of Respiratory Medicine 14:4, pages 345-351.
Read now
Read now
Holly McCabe, Brian Godman, Amanj Kurdi, Katie Johnston, Sean MacBride-Stewart, Janey Lennon, Simon Hurding, Marion Bennie & Alec Morton. (2019) Prescribing trends of inhaler treatments for asthma and chronic obstructive pulmonary disease within a resource-constrained environment in the Scottish national health service: findings and implications. Expert Review of Respiratory Medicine 13:7, pages 679-689.
Read now
Read now
Marjolein Engelkes, Jan C. van Blijderveen, Jetty A. Overbeek, Josephine Kuiper, Ron C. M. Herings, Miriam C. J. M. Sturkenboom, Johan C. de Jongste, Katia M. C. Verhamme & Hettie M. Janssens. (2018) Brand and generic use of inhalation medication and frequency of switching in children and adults: A population-based cohort study. Journal of Asthma 55:10, pages 1086-1094.
Read now
Read now
Fulvio Braido, Federico Lavorini, Francesco Blasi, Ilaria Baiardini & Giorgio Walter Canonica. (2015) Switching treatments in COPD: implications for costs and treatment adherence. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 2601-2608.
Read now
Read now
Anne H de Boer & Paul Hagedoorn. (2015) The role of disposable inhalers in pulmonary drug delivery. Expert Opinion on Drug Delivery 12:1, pages 143-157.
Read now
Read now
Stephen Newman. (2014) Improving inhaler technique, adherence to therapy and the precision of dosing: major challenges for pulmonary drug delivery. Expert Opinion on Drug Delivery 11:3, pages 365-378.
Read now
Read now
Articles from other publishers (23)
AmrS Albanna, Mohammed Alhajji, Waleed Alsowayan & MohamedHany Soliman. (2023) The impact of unsupervised and unconsented switch of inhalers in patients with controlled asthma – A targeted literature review. Annals of Thoracic Medicine 18:3, pages 103.
Crossref
Crossref
Federico Lavorini, Omar S. Usmani & Rajiv Dhand. (2021) Aerosol delivery systems for treating obstructive airway diseases during the SARS-CoV-2 pandemic. Internal and Emergency Medicine 16:8, pages 2035-2039.
Crossref
Crossref
A. V. BadarinathS A SreenivasM. Suresh Babu. (2021) REVIEW ON DRY POWDER INHALERS: CURRENT ADVANCES AND LIMITATIONS. PARIPEX INDIAN JOURNAL OF RESEARCH, pages 63-67.
Crossref
Crossref
Biljana Cvetkovski, Charlotte Hespe, Rachel Tan, Vicky Kritikos, Elizabeth Azzi & Sinthia Bosnic-Anticevich. (2020) General Practitioner Use of Generically Substitutable Inhaler Devices and the Impact of Training on Device Mastery and Maintenance of Correct Inhaler Technique. Pulmonary Therapy 6:2, pages 315-331.
Crossref
Crossref
Gustaf Ortsäter, Fredrik Borgström, Mike Baldwin & Carolin Miltenburger. (2019) Incorporating the Environmental Impact into a Budget Impact Analysis: The Example of Adopting RESPIMAT® Re-usable Inhaler. Applied Health Economics and Health Policy 18:3, pages 433-442.
Crossref
Crossref
Michael G. Kirby, Paula Allchorne, Tim Appanna, Patrick Davey, Richard Gledhill, James S. A. Green, Damian Greene & Derek J. Rosario. (2019) Prescription switching: Rationales and risks. International Journal of Clinical Practice 74:1.
Crossref
Crossref
Hannah A. Blair. (2019) Fluticasone propionate/salmeterol (Wixela® Inhub®) dry-powder inhaler in asthma and COPD: a profile of its use in the USA. Drugs & Therapy Perspectives 35:12, pages 583-591.
Crossref
Crossref
Gustaf Ortsäter, Fredrik Borgström, Stéphane Soulard & Carolin Miltenburger. (2019) A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT® Re-usable in the Nordics and Benelux. Advances in Therapy 36:12, pages 3435-3445.
Crossref
Crossref
Chloe I Bloom, Ian Douglas, Jack Olney, Grainne D'Ancona, Liam Smeeth & Jennifer K Quint. (2019) Cost saving of switching to equivalent inhalers and its effect on health outcomes. Thorax 74:11, pages 1078-1086.
Crossref
Crossref
Esther Kuipers, Michel Wensing, Elaine Wong-Go, Bernard J. G. Daemen, Peter A. G. M. De Smet & Martina Teichert. (2019) Adherence to guideline recommendations for asthma care in community pharmacies: actual and needed performance. npj Primary Care Respiratory Medicine 29:1.
Crossref
Crossref
Markus WolkenhauerKirsten LatzaJoachim JungNorbert EckhardFrank Götzmann. (2019) Effect of Unintentional Storage and Handling Errors of Inhaled Medications: What Does This Mean for Therapeutic Equivalence Considerations?. Journal of Aerosol Medicine and Pulmonary Drug Delivery 32:3, pages 121-131.
Crossref
Crossref
Hong-Goo Lee, Dong-Wook Kim & Chung-Woong Park. (2017) Dry powder inhaler for pulmonary drug delivery: human respiratory system, approved products and therapeutic equivalence guideline. Journal of Pharmaceutical Investigation 48:6, pages 603-616.
Crossref
Crossref
Federico Lavorini, Massimo Pistolesi & Omar S. Usmani. (2017) Recent advances in capsule-based dry powder inhaler technology. Multidisciplinary Respiratory Medicine 12:1.
Crossref
Crossref
Sara Rahimkhani, Saeed Ghanbarzadeh, Ali Nokhodchi & Hamed Hamishehkar. (2017) An In Vitro Aerosolization Efficiency Comparison of Generic and Branded Salbutamol Metered Dose Inhalers. Pharmaceutical Sciences 23:1, pages 77-81.
Crossref
Crossref
Zuzana Diamant & Nicola A. Hanania. (2017) Generic medications in precision medicine in asthma. Current Opinion in Pulmonary Medicine 23:1, pages 1-2.
Crossref
Crossref
Birger Norderud Lærum, Gunilla Telg & Georgios Stratelis. (2016) Need of education for dry powder inhaler storage and retention – a patient-reported survey. Multidisciplinary Respiratory Medicine 11:1.
Crossref
Crossref
Christer Janson, Thomas Lööf, Gunilla Telg, Georgios Stratelis & Folke Nilsson. (2016) Difference in resistance to humidity between commonly used dry powder inhalers: an in vitro study. npj Primary Care Respiratory Medicine 26:1.
Crossref
Crossref
Jolyon Mitchell. 2016. Developing Drug Products in an Aging Society. Developing Drug Products in an Aging Society
331
382
.
Matteo Bonini & Omar S. Usmani. (2015) The importance of inhaler devices in the treatment of COPD. COPD Research and Practice 1:1.
Crossref
Crossref
A. Ekberg-Jansson, I. Svenningsson, P. Rågdell, G. Stratelis, G. Telg, M. Thuresson & F. Nilsson. (2015) Budesonide inhaler device switch patterns in an asthma population in Swedish clinical practice (ASSURE). International Journal of Clinical Practice 69:10, pages 1171-1178.
Crossref
Crossref
Federico Lavorini, Fulvio Braido, Ilaria Baiardini, Francesco Blasi & Giorgio Walter Canonica. (2015) Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR). Pulmonary Pharmacology & Therapeutics 34, pages 25-30.
Crossref
Crossref
P. Devillier, H. Salvator & N. Roche. (2015) Le choix du dispositif d’inhalation (hors nébulisation) : un acte médical. Revue des Maladies Respiratoires 32:6, pages 599-607.
Crossref
Crossref
M. Hoppentocht, P. Hagedoorn, H.W. Frijlink & A.H. de Boer. (2014) Technological and practical challenges of dry powder inhalers and formulations. Advanced Drug Delivery Reviews 75, pages 18-31.
Crossref
Crossref